AR028596A1 - Nuevos derivados de fenilglicina - Google Patents
Nuevos derivados de fenilglicinaInfo
- Publication number
- AR028596A1 AR028596A1 ARP010102385A ARP010102385A AR028596A1 AR 028596 A1 AR028596 A1 AR 028596A1 AR P010102385 A ARP010102385 A AR P010102385A AR P010102385 A ARP010102385 A AR P010102385A AR 028596 A1 AR028596 A1 AR 028596A1
- Authority
- AR
- Argentina
- Prior art keywords
- phenylglycin
- new derivatives
- derivatives
- new
- Prior art date
Links
- ZGUNAGUHMKGQNY-UHFFFAOYSA-N alpha-phenylglycine Chemical class OC(=O)C(N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D317/34—Oxygen atoms
- C07D317/36—Alkylene carbonates; Substituted alkylene carbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
- C07C259/18—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00110881 | 2000-05-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR028596A1 true AR028596A1 (es) | 2003-05-14 |
Family
ID=8168800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010102385A AR028596A1 (es) | 2000-05-23 | 2001-05-21 | Nuevos derivados de fenilglicina |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6548694B2 (es) |
| EP (1) | EP1289939A1 (es) |
| JP (1) | JP3842132B2 (es) |
| KR (1) | KR100569517B1 (es) |
| CN (1) | CN1305839C (es) |
| AR (1) | AR028596A1 (es) |
| AU (2) | AU2001281774B2 (es) |
| BR (1) | BR0110998A (es) |
| CA (1) | CA2408602C (es) |
| EC (1) | ECSP024360A (es) |
| HU (1) | HUP0302073A2 (es) |
| IL (1) | IL152581A0 (es) |
| MA (1) | MA26905A1 (es) |
| MX (1) | MXPA02011466A (es) |
| NO (1) | NO20025590D0 (es) |
| NZ (1) | NZ522412A (es) |
| PE (1) | PE20011314A1 (es) |
| PL (1) | PL361355A1 (es) |
| RU (1) | RU2268257C2 (es) |
| UY (1) | UY26721A1 (es) |
| WO (1) | WO2001090051A1 (es) |
| YU (1) | YU83602A (es) |
| ZA (1) | ZA200208899B (es) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000035858A1 (en) * | 1998-12-14 | 2000-06-22 | F. Hoffmann-La Roche Ag | Phenylglycine derivatives |
| DE10300049A1 (de) * | 2003-01-03 | 2004-07-15 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen, die Faktor VIIa inhibieren |
| US6642386B2 (en) * | 2002-02-06 | 2003-11-04 | Hoffmann-La Roche Inc. | N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| GB0211931D0 (en) * | 2002-05-23 | 2002-07-03 | Univ Liverpool | Methods & device utilizing adsorption of molecules at a surface or interface |
| TW200410921A (en) * | 2002-11-25 | 2004-07-01 | Hoffmann La Roche | Mandelic acid derivatives |
| US7122559B2 (en) | 2003-02-11 | 2006-10-17 | Bristol-Myers Squibb Company | Phenylglycine derivatives useful as serine protease inhibitors |
| WO2004072102A2 (en) | 2003-02-11 | 2004-08-26 | Bristol-Myers Squibb Company | Benzene acetamide compounds useful as serine protease inhibitors |
| DE10306202A1 (de) | 2003-02-13 | 2004-08-26 | Grünenthal GmbH | Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen |
| US7917130B1 (en) | 2003-03-21 | 2011-03-29 | Stratosaudio, Inc. | Broadcast response method and system |
| US7776804B2 (en) * | 2005-03-16 | 2010-08-17 | The Lubrizol Corporation | Viscosity improver compositions providing improved low temperature characteristics to lubricating oil |
| US7056932B2 (en) * | 2003-12-19 | 2006-06-06 | Hoffman-La Roche Inc. | Heterocyclyl substituted 1-alkoxy acetic acid amides |
| EP1810965A4 (en) * | 2004-10-13 | 2009-10-28 | Eisai R&D Man Co Ltd | HYDRAZIDE DERIVATIVES |
| EP2332527A3 (en) * | 2004-10-20 | 2011-11-16 | Resverlogix Corp. | Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases |
| DE602006016566D1 (de) | 2005-01-10 | 2010-10-14 | Bristol Myers Squibb Co | Als antikoagulanzien verwendbare phenylglycinamid-derivate |
| WO2007002313A2 (en) * | 2005-06-24 | 2007-01-04 | Bristol-Myers Squibb Company | Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants |
| US8044242B2 (en) | 2006-03-09 | 2011-10-25 | Bristol-Myers Squibb Company | 2-(aryloxy) acetamide factor VIIa inhibitors useful as anticoagulants |
| JP5016592B2 (ja) * | 2006-03-24 | 2012-09-05 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | トリアゾロン誘導体 |
| US7855194B2 (en) | 2006-03-27 | 2010-12-21 | Hoffmann-La Roche Inc. | Pyrimidine, quinazoline, pteridine and triazine derivatives |
| KR101444489B1 (ko) | 2007-02-01 | 2014-09-24 | 리스버로직스 코퍼레이션 | 심혈관 질환을 예방 및 치료하기 위한 화합물 |
| EP1967522A1 (en) * | 2007-03-07 | 2008-09-10 | Novo Nordisk A/S | New blood coagulation factor inhibitors |
| JPWO2009038157A1 (ja) * | 2007-09-21 | 2011-01-06 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ２，３−ジヒドロ−イミノイソインドール誘導体 |
| WO2009079417A1 (en) | 2007-12-14 | 2009-06-25 | Stratosaudio, Inc. | Systems and methods for scheduling interactive media and events |
| US8114995B2 (en) * | 2008-06-26 | 2012-02-14 | Resverlogix Corp. | Methods of preparing quinazolinone derivatives |
| ES2542835T3 (es) | 2009-01-08 | 2015-08-12 | Resverlogix Corporation | Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares |
| KR101841003B1 (ko) | 2009-03-18 | 2018-03-22 | 리스버로직스 코퍼레이션 | 신규한 소염제 |
| US9757368B2 (en) | 2009-04-22 | 2017-09-12 | Resverlogix Corp. | Anti-inflammatory agents |
| CN102887836B (zh) * | 2011-07-18 | 2014-03-26 | 西南大学 | L-苯甘氨酸衍生物及其应用 |
| US9610251B2 (en) | 2011-11-01 | 2017-04-04 | Resverlogix Corp. | Pharmaceutical compositions for substituted quinazolinones |
| GB201118876D0 (en) * | 2011-11-01 | 2011-12-14 | Astex Therapeutics Ltd | Pharmaceutical compounds |
| US9765039B2 (en) | 2012-11-21 | 2017-09-19 | Zenith Epigenetics Ltd. | Biaryl derivatives as bromodomain inhibitors |
| WO2014080290A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Cyclic amines as bromodomain inhibitors |
| WO2014096965A2 (en) | 2012-12-21 | 2014-06-26 | Rvx Therapeutics Inc. | Novel heterocyclic compounds as bromodomain inhibitors |
| CN107530356A (zh) | 2015-03-13 | 2018-01-02 | 雷斯韦洛吉克斯公司 | 用于治疗补体相关疾病之组合物及治疗方法 |
| CN111072562B (zh) * | 2019-11-07 | 2021-12-07 | 中山大学 | 一种四氢异喹啉衍生物及其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2008116C (en) * | 1989-02-23 | 2001-11-20 | Thomas Weller | Glycine derivatives |
| DE4421052A1 (de) * | 1994-06-17 | 1995-12-21 | Basf Ag | Neue Thrombininhibitoren, ihre Herstellung und Verwendung |
| SI0921116T1 (en) | 1997-12-04 | 2003-10-31 | F. Hoffmann - La Roche Ag | N-(4-carbamimido-phenyl)-glycine amide derivatives |
| AU2300699A (en) | 1998-02-17 | 1999-08-30 | Ono Pharmaceutical Co. Ltd. | Amidino derivatives and drugs containing the same as the active ingredient |
| WO2000035858A1 (en) * | 1998-12-14 | 2000-06-22 | F. Hoffmann-La Roche Ag | Phenylglycine derivatives |
-
2001
- 2001-05-16 US US09/858,535 patent/US6548694B2/en not_active Expired - Fee Related
- 2001-05-17 AU AU2001281774A patent/AU2001281774B2/en not_active Ceased
- 2001-05-17 MX MXPA02011466A patent/MXPA02011466A/es active IP Right Grant
- 2001-05-17 PE PE2001000442A patent/PE20011314A1/es not_active Application Discontinuation
- 2001-05-17 RU RU2002133215/04A patent/RU2268257C2/ru active
- 2001-05-17 YU YU83602A patent/YU83602A/sh unknown
- 2001-05-17 CA CA002408602A patent/CA2408602C/en not_active Expired - Fee Related
- 2001-05-17 BR BR0110998-7A patent/BR0110998A/pt not_active IP Right Cessation
- 2001-05-17 WO PCT/EP2001/005633 patent/WO2001090051A1/en not_active Ceased
- 2001-05-17 NZ NZ522412A patent/NZ522412A/en unknown
- 2001-05-17 HU HU0302073A patent/HUP0302073A2/hu unknown
- 2001-05-17 PL PL36135501A patent/PL361355A1/xx not_active Application Discontinuation
- 2001-05-17 EP EP01960221A patent/EP1289939A1/en not_active Withdrawn
- 2001-05-17 JP JP2001586241A patent/JP3842132B2/ja not_active Expired - Fee Related
- 2001-05-17 AU AU8177401A patent/AU8177401A/xx active Pending
- 2001-05-17 KR KR1020027015798A patent/KR100569517B1/ko not_active Expired - Fee Related
- 2001-05-17 IL IL15258101A patent/IL152581A0/xx unknown
- 2001-05-17 CN CNB018099297A patent/CN1305839C/zh not_active Expired - Fee Related
- 2001-05-21 AR ARP010102385A patent/AR028596A1/es not_active Application Discontinuation
- 2001-05-22 UY UY26721A patent/UY26721A1/es not_active Application Discontinuation
-
2002
- 2002-11-01 ZA ZA200208899A patent/ZA200208899B/en unknown
- 2002-11-21 NO NO20025590A patent/NO20025590D0/no not_active Application Discontinuation
- 2002-11-22 MA MA26921A patent/MA26905A1/fr unknown
- 2002-11-22 EC EC2002004360A patent/ECSP024360A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL152581A0 (en) | 2003-05-29 |
| UY26721A1 (es) | 2001-12-28 |
| JP2003534311A (ja) | 2003-11-18 |
| MA26905A1 (fr) | 2004-12-20 |
| EP1289939A1 (en) | 2003-03-12 |
| YU83602A (sh) | 2006-05-25 |
| ZA200208899B (en) | 2004-02-19 |
| AU2001281774B2 (en) | 2005-03-10 |
| PL361355A1 (en) | 2004-10-04 |
| WO2001090051A1 (en) | 2001-11-29 |
| CN1305839C (zh) | 2007-03-21 |
| CN1430599A (zh) | 2003-07-16 |
| NZ522412A (en) | 2004-05-28 |
| JP3842132B2 (ja) | 2006-11-08 |
| CA2408602A1 (en) | 2001-11-29 |
| US20020004608A1 (en) | 2002-01-10 |
| HUP0302073A2 (hu) | 2003-09-29 |
| KR100569517B1 (ko) | 2006-04-07 |
| AU8177401A (en) | 2001-12-03 |
| US6548694B2 (en) | 2003-04-15 |
| BR0110998A (pt) | 2003-04-08 |
| MXPA02011466A (es) | 2003-04-25 |
| NO20025590L (no) | 2002-11-21 |
| CA2408602C (en) | 2008-01-08 |
| PE20011314A1 (es) | 2002-01-04 |
| ECSP024360A (es) | 2003-03-31 |
| KR20030007678A (ko) | 2003-01-23 |
| NO20025590D0 (no) | 2002-11-21 |
| RU2268257C2 (ru) | 2006-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR028567A1 (es) | Nuevos derivados de fenil-propargileter | |
| AR028596A1 (es) | Nuevos derivados de fenilglicina | |
| DK1292604T3 (da) | 2-Aminocarbonyl-9H-purinderivater | |
| PT1303521E (pt) | Derivados de tetra-hidro-heterocicloazepinil-pirimidina | |
| DK1280809T3 (da) | Antitumorecteinascidinderivater | |
| ID30187A (id) | Dongkrak jenis pantagraf | |
| ATE298332T1 (de) | Decahydro-isochinolinderivate | |
| PT1250321E (pt) | Composicao de gliburida | |
| ATE414056T1 (de) | Substituierte c-cyclohexylmethylamin-derivative | |
| FR2810318B1 (fr) | Derives de diamano-phenothiazine | |
| AR028602A1 (es) | Derivados de pirrol | |
| AR028282A1 (es) | Derivados de aminofenil pirimidona | |
| PT1322592E (pt) | Derivados substituidos de 1-aminobutan-3-ol | |
| ATE282021T1 (de) | Substituierte aminomethyl-phenyl- cyclohexanderivate | |
| PT1351959E (pt) | Novos derivados de pleuromutilina | |
| AR028607A1 (es) | Derivados de 1,4-diazepan-2,5-diona | |
| PT1246791E (pt) | Derivados de aminometilfenilciclo-hexanona | |
| PT1178984E (pt) | Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano | |
| ATE361274T1 (de) | Substituierte 5-amino-1-penten-3-ol-derivate | |
| ATE374776T1 (de) | Pyrrolotriazolopyrimidinonderivate | |
| NO20024393D0 (no) | 2-fenylpyran-4-on-derivater | |
| PT1232141E (pt) | Eteres de o-desmetil-venlafaxina | |
| FR2810531B1 (fr) | Trocart de coelio-chirurgie | |
| UA4579S (uk) | Дозиметр-радіометр гамма-бета-випромінювань | |
| DK1246793T3 (da) | Substituerede aminomethyl-phenyl-cyclohexanderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |